Common Nerve Injuries in Upper Limb Trauma

The upper limb is susceptible to various nerve injuries following trauma. Here are some of the most common nerve injuries that can occur in the upper limb:

Axillary nerve: Shoulder dislocation can cause injury to the axillary nerve, which innervates the deltoid muscle. Sensation in the skin innervated by the superior lateral cutaneous nerve can be tested as an alternative.

Radial nerve: Mid-humeral shaft fractures can damage the radial nerve, which provides sensation to the dorsum of the hand and innervates the extensor compartment of the forearm.

Ulnar nerve: Cubital tunnel syndrome and fracture of the medial epicondyle can cause ulnar nerve injury, leading to weakness in wrist flexion and a claw hand deformity.

Median nerve: Supracondylar humerus fractures, wearing a tight forearm case, wrist laceration, or carpal tunnel syndrome can injure the median nerve, causing sensory loss and motor deficits such as loss of pronation in the forearm, weakness in wrist flexion, and loss of thumb opposition.

Musculocutaneous nerve: The musculocutaneous nerve gives rise to the lateral cutaneous nerve of the forearm, while the cutaneous distribution of the median and ulnar nerves is located more distally to the hand.

In conclusion, understanding the common nerve injuries that can occur in upper limb trauma is crucial for proper diagnosis and treatment.

The preferred treatment for Paget’s disease of the bone is bisphosphonates, which inhibit osteoblastic activity. This patient’s symptoms, including bone pain, headaches, and hearing loss, along with elevated ALP levels, suggest a diagnosis of Paget’s disease. While calcium supplements may be useful for other conditions, they are not indicated for Paget’s disease, as calcium levels are typically normal. Triptans, codeine, and a Cochlear implant are also not appropriate treatments for this condition.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

The underlying cause of Marfan syndrome is a genetic mutation in the fibrillin-1 protein, which plays a crucial role as a substrate for elastin.

Understanding Marfan’s Syndrome

Marfan’s syndrome is a genetic disorder that affects the connective tissue in the body. It is caused by a defect in the FBN1 gene on chromosome 15, which codes for the protein fibrillin-1. This disorder is inherited in an autosomal dominant pattern, meaning that a person only needs to inherit one copy of the defective gene from one parent to develop the condition. Marfan’s syndrome affects approximately 1 in 3,000 people.

The features of Marfan’s syndrome include a tall stature with an arm span to height ratio greater than 1.05, a high-arched palate, arachnodactyly (long, slender fingers), pectus excavatum (sunken chest), pes planus (flat feet), and scoliosis (curvature of the spine). In addition, individuals with Marfan syndrome may experience cardiovascular problems such as dilation of the aortic sinuses, mitral valve prolapse, and aortic aneurysm. They may also have lung issues such as repeated pneumothoraces. Eye problems are also common, including upwards lens dislocation, blue sclera, and myopia. Finally, dural ectasia, or ballooning of the dural sac at the lumbosacral level, may also occur.

In the past, the life expectancy of individuals with Marfan syndrome was around 40-50 years. However, with regular echocardiography monitoring and the use of beta-blockers and ACE inhibitors, this has improved significantly in recent years. Despite these improvements, aortic dissection and other cardiovascular problems remain the leading cause of death in individuals with Marfan syndrome.

To address the patient’s significant tachycardia, the initial course of action would be to conduct an ECG. If the results reveal QRS widening, administering intravenous bicarbonate is recommended. While some suggest an ‘ABC’ approach with flumazenil to counteract respiratory depression, caution must be exercised due to the risk of inducing seizures in the presence of tricyclic overdose.

Tricyclic overdose is a common occurrence in emergency departments, with particular danger associated with amitriptyline and dosulepin. Early symptoms include dry mouth, dilated pupils, agitation, sinus tachycardia, and blurred vision. Severe poisoning can lead to arrhythmias, seizures, metabolic acidosis, and coma. ECG changes may include sinus tachycardia, widening of QRS, and prolongation of QT interval. QRS widening over 100ms is linked to an increased risk of seizures, while QRS over 160 ms is associated with ventricular arrhythmias.

Management of tricyclic overdose involves IV bicarbonate as first-line therapy for hypotension or arrhythmias. Other drugs for arrhythmias, such as class 1a and class Ic antiarrhythmics, are contraindicated as they prolong depolarisation. Class III drugs like amiodarone should also be avoided as they prolong the QT interval. Lignocaine’s response is variable, and it should be noted that correcting acidosis is the first line of management for tricyclic-induced arrhythmias. Intravenous lipid emulsion is increasingly used to bind free drug and reduce toxicity. Dialysis is ineffective in removing tricyclics.

When women who are taking antiepileptic medication plan to conceive, they should be given a higher dose of folic acid (5mg) instead of the usual 400 mcg once daily. Folic acid is recommended during pregnancy to prevent neural tube defects, and a higher dose is necessary for women with epilepsy due to their increased risk of low serum folate levels. It is important to note that certain antiepileptic medications can interfere with folate metabolism, and switching to sodium valproate is not recommended as it is a known teratogen. It is also important for women to continue taking their medication during pregnancy to avoid an increased risk of seizures.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. It is found in green, leafy vegetables and plays a crucial role in the transfer of 1-carbon units to essential substrates involved in the synthesis of DNA and RNA. However, certain factors such as phenytoin, methotrexate, pregnancy, and alcohol excess can cause a deficiency in folic acid. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, it is recommended that all women take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if they or their partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with certain medical conditions such as coeliac disease, diabetes, or thalassaemia trait, or those taking antiepileptic drugs, or who are obese (BMI of 30 kg/m2 or more) are also considered higher risk.

In summary, folic acid is an essential nutrient that plays a crucial role in DNA and RNA synthesis. Deficiency in folic acid can lead to serious health consequences, including neural tube defects. However, taking folic acid supplements during pregnancy can prevent these defects and ensure a healthy pregnancy.

The American Society of Anaesthesiologists (ASA) classification is a system used to categorize patients based on their overall health status and the potential risks associated with administering anesthesia. There are six different classifications, ranging from ASA I (a normal healthy patient) to ASA VI (a declared brain-dead patient whose organs are being removed for donor purposes).

ASA II patients have mild systemic disease, but without any significant functional limitations. Examples of mild diseases include current smoking, social alcohol drinking, pregnancy, obesity, and well-controlled diabetes mellitus or hypertension. ASA III patients have severe systemic disease and substantive functional limitations, with one or more moderate to severe diseases. Examples include poorly controlled diabetes mellitus or hypertension, COPD, morbid obesity, active hepatitis, alcohol dependence or abuse, implanted pacemaker, moderate reduction of ejection fraction, End-Stage Renal Disease (ESRD) undergoing regularly scheduled dialysis, history of myocardial infarction, and cerebrovascular accidents.

ASA IV patients have severe systemic disease that poses a constant threat to life, such as recent myocardial infarction or cerebrovascular accidents, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD, or ESRD not undergoing regularly scheduled dialysis. ASA V patients are moribund and not expected to survive without the operation, such as ruptured abdominal or thoracic aneurysm, massive trauma, intracranial bleed with mass effect, ischaemic bowel in the face of significant cardiac pathology, or multiple organ/system dysfunction. Finally, ASA VI patients are declared brain-dead and their organs are being removed for donor purposes.

If a baby has a birth weight greater than 4kg, regardless of their gestational age, they are diagnosed with foetal macrosomia. This condition can cause dystocia, which may result in injuries to both the mother and baby. Dystocia may also require an operative vaginal delivery or Caesarean-section. Shoulder dystocia is the most common cause of damage to the upper brachial plexus, resulting in Erb’s palsy. This condition is characterized by the arm being adducted and internally rotated, with the forearm pronated, commonly referred to as the ‘waiter’s tip’. Damage to the lower brachial plexus can cause Klumpke’s palsy, which commonly affects the nerves that innervate the muscles of the hand.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the fetus. Risk factors for shoulder dystocia include fetal macrosomia, high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior help immediately. The McRoberts’ maneuver is often performed, which involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant maternal morbidity. Oxytocin administration is not indicated for shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury and neonatal death for the fetus. It is important to manage shoulder dystocia promptly and appropriately to minimize the risk of these complications.

Understanding the Causes of Hyponatraemia: Differential Diagnosis

Hyponatraemia is a condition characterized by low levels of sodium in the blood. There are several possible causes of hyponatraemia, including the syndrome of inappropriate antidiuretic hormone secretion (SIADH), primary adrenal insufficiency, diuretics, polydipsia, and vomiting.

SIADH is a common cause of hyponatraemia, particularly in small cell lung cancer patients. It occurs due to the ectopic production of antidiuretic hormone (ADH), which leads to impaired water excretion and water retention. This results in hyponatraemia and hypo-osmolality.

Primary adrenal insufficiency, also known as Addison’s disease, can also cause hyponatraemia, hyperkalaemia, and hypotension. However, there is no indication in the question that the patient has this condition.

Diuretics, particularly loop diuretics and bendroflumethiazide, can also cause hyponatraemia. However, there is no information to suggest that the patient is taking diuretics.

Polydipsia, or excessive thirst, can also lead to hyponatraemia. However, there is no indication in the question that the patient has this condition.

Vomiting is another possible cause of hyponatraemia, but there is no information in the question to support this as a correct answer.

In summary, hyponatraemia can have several possible causes, and a thorough differential diagnosis is necessary to determine the underlying condition.

The most probable diagnosis for an old man experiencing bone pain and raised ALP is Paget’s disease, as it often presents with skull vault expansion and sensorineural hearing loss. While multiple myeloma may also cause bone pain, it typically results in multiple areas of radiolucency and raised calcium levels. Although osteopetrosis can cause similar symptoms, it is a rare inherited disorder that usually presents in children or young adults, making it an unlikely diagnosis for an older patient without prior symptoms.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

Proper Steps for Moving a Patient to a Place of Safety

When a patient needs to be assessed in a place of safety, it is important to follow the proper steps to ensure their well-being and respect their rights. One option is to apply to a Sheriff or Justice of the Peace for a grant of warrant to remove the patient to a hospital. However, if the patient has a reduced consciousness level or there is an immediate threat to life, common law can be applied to transfer them to the hospital.

It is crucial to remember that every person has the right to be treated with dignity and respect, receive treatment that meets professional standards, live free from abuse and discrimination, get the care that suits their needs, and lead a fulfilling life. Any action that breaches these principles must be rejected.

Assuming a patient’s decision-making capacity without proper assessment is not acceptable. Physically moving the patient against their will can be considered assault and is not the correct course of action. Lying to the patient is unprofessional and unethical.

If necessary, a psychiatrist can be asked to undertake a formal assessment of the patient, but only after they have been moved to a safe place, such as a hospital. By following these proper steps, the patient’s well-being and rights can be protected.